Some studies suggest that EpCAM can be used as a predictor of prostate cancer; it has an important activity in CaP proliferation, invasion, metastasis, and chemo-/radio-resistance associated with the activation of the PI3K/Akt/mTOR signaling pathway [71]. This evidence concerns the gene EPCAM and Familial prostate cancer.